Author Archives: Paul Sloane

The Medical Innovation Bill

We are living in an increasingly litigious age. The number of lawsuits brought against the British National Health Service has doubled in the last four years. The fear of litigation and the real possibility of been found guilty of medical malpractice are inhibiting hospitals and doctors from trying promising new ideas in the treatment of deadly illnesses. Lord Saatchi has introduced into Parliament a Medical Innovation Bill which aims to encourage responsible scientific experimentation in medicine.

Read More »

Three Friends vs. Three Enemies of Innovation

Support the VCC and fight the BBC. For most organizations innovation is a struggle. The natural thing to do is to stay in the current state. The CEO preaches the need for innovation but people further down know that it involves risk, time, effort, cost, disruption and potential failure. In this contest innovation has some powerful friends and some dangerous enemies.

Read More »

Radovation and Incrovation

Francisco González Bree, Academic Director for the Master of Business Innovation (MBI) course at the University of Deusto in Spain says, ‘ The term “innovation” is losing its genuine meaning because many companies are using it to convey change when the progress they are describing is no more than ordinary.’

Read More »